33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) (vol 6, pg 115, 2018)

被引:10
|
作者
Berry, Sneha [1 ]
Giraldo, Nicolas [1 ]
Nguyen, Peter [1 ]
Green, Benjamin [1 ]
Xu, Haiying [1 ]
Ogurtsova, Aleksandra [1 ]
Soni, Abha [1 ]
Succaria, Farah [1 ]
Wang, Daphne [1 ]
Roberts, Charles [1 ]
Stein, Julie [1 ]
Engle, Elizabeth [1 ]
Pardoll, Drew [1 ]
Anders, Robert [1 ]
Cottrell, Tricia [1 ]
Taube, Janis M. [1 ]
Tran, Ben [3 ]
Voskoboynik, Mark [4 ]
Kuo, James [5 ]
Bang, Yung-Lue [6 ]
Chung, Hyun-Cheo [7 ]
Ahn, Myung-Ju [8 ]
Kim, Sang-We [9 ]
Perera, Ayesh [2 ]
Freeman, Daniel [2 ]
Achour, Ikbel [2 ]
Faggioni, Raffaella [2 ]
Xiao, Feng [2 ]
Ferte, Charles [2 ]
Lemech, Charlotte [5 ]
Meric-Bernstam, Funda [10 ,19 ]
Werner, Theresa [11 ]
Hodi, Stephen [12 ]
Messersmith, Wells [13 ]
Lewis, Nancy [14 ]
Talluto, Craig [15 ]
Dostalek, Mirek [14 ]
Tao, Aiyang [14 ]
McWhirter, Sarah [16 ]
Trujillo, Damian [16 ]
Luke, Jason [17 ]
Xu, Chunxiao [18 ]
BoMarelli [18 ]
Qi, Jin [18 ]
Qin, Guozhong [18 ]
Yu, Huakui [18 ]
Jenkins, Molly [18 ]
Lo, Kin-Ming [18 ]
Halle, Joern-Peter [18 ]
Lan, Yan [18 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] MedImmune, Gaithersburg, MD 20878 USA
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Nucleus Network, Melbourne, Australia
[5] Sci Clin Res, Sydney, NSW, Australia
[6] Seoul Natl Univ Hosp, Seoul, South Korea
[7] Yonsei Univ, Yonsei Canc Ctr, Seoul, South Korea
[8] Samsung Med Ctr, Seoul, South Korea
[9] Asan Med Ctr, Seoul, South Korea
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Univ Utah, Salt Lake City, UT USA
[12] Dana Faber Canc Inst, Boston, MA USA
[13] Univ Colorado, Canc Ctr, Aurora, CO USA
[14] Novartis Pharmaceut, E Hanover, NJ USA
[15] Novartis Inst BioMed Resea, Cambridge, MA USA
[16] Aduro Biotech Inc, Berkeley, CA USA
[17] Aduro Biotech Inc, Chicago, IL USA
[18] EMD Serono Res & Dev, Belmont, MA 01821 USA
[19] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[20] McKesson Specialty Hlth, Las Vegas, NV 89169 USA
[21] Eisai Inc, Woodcliff Lake, NJ USA
[22] Merck & Co Inc, Kenilworth, NJ USA
[23] South Texas Accelerated Res Therape, San Antonio, TX USA
[24] Abramson Canc Ctr Univ, Philadelphia, PA 19380 USA
[25] McKesson Specialty Hlth, Las Vegas, NV USA
[26] South Texas Accelerated Res Therape, San Antonio, TX USA
[27] Eisai Inc, Woodcliff Lake, NJ USA
[28] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[29] Ewha Womans Univ, Seoul, South Korea
[30] MD Healthcare Co, Seoul, South Korea
[31] Natl Univ Canc Inst, Singapore, Singapore
[32] Vall dHebron Inst Oncol, Barcelona, Spain
[33] Canc Inst Hosp JFCR, Tokyo, Japan
[34] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[35] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[36] Novartis Pharmaceut, E Hanover, NJ USA
[37] Novartis Inst BioMed Resea, Cambridge, MA USA
[38] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词
IPILIMUMAB; PEMBROLIZUMAB; NIVOLUMAB;
D O I
10.1186/s40425-019-0519-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
After publication of this supplement [1, 2], it was brought to our attention that due to an error authors were missing in the following abstracts. This has now been included in this correction.
引用
收藏
页数:11
相关论文
共 31 条